Daily use of consensus interferon CIFN for treatment of chronic hepatitis C patients relapsing or non responding to previous IFN alpha 2b or 2a administration preliminary report of results at 12th week


HÜLAGÜ S.

Gastroenterology 116(4) G3237, part 2 APR 1999.(Ayrıca bu çalışma American College of Gastroenterology 64th Annual Scientific Meeting October 18-20 1999 toplantısında sunulmuştur.), 18 - 20 October 2000

  • Publication Type: Conference Paper / Summary Text